Loading…

Qualitative and Quantitative Requirements for CD4+ T Cell-Mediated Antiviral Protection

CD4+ Th cells deliver the cognate and cytokine signals that promote the production of protective virus-neutralizing IgG by specific B cells and are also able to mediate direct antiviral effector functions. To quantitatively and qualitatively analyze the antiviral functions of CD4+ Th cells, we gener...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of immunology (1950) 1999-03, Vol.162 (5), p.2867-2874
Main Authors: Maloy, Kevin J, Burkhart, Christoph, Freer, Giulia, Rulicke, Thomas, Pircher, Hanspeter, Kono, Dwight H, Theofilopoulos, Argyrios N, Ludewig, Burkhard, Hoffmann-Rohrer, Urs, Zinkernagel, Rolf M, Hengartner, Hans
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c380t-88f8cbd3c6db3f3ea8cb626115c11354a278e31d693994278efadccaea4b3d9e3
cites cdi_FETCH-LOGICAL-c380t-88f8cbd3c6db3f3ea8cb626115c11354a278e31d693994278efadccaea4b3d9e3
container_end_page 2874
container_issue 5
container_start_page 2867
container_title The Journal of immunology (1950)
container_volume 162
creator Maloy, Kevin J
Burkhart, Christoph
Freer, Giulia
Rulicke, Thomas
Pircher, Hanspeter
Kono, Dwight H
Theofilopoulos, Argyrios N
Ludewig, Burkhard
Hoffmann-Rohrer, Urs
Zinkernagel, Rolf M
Hengartner, Hans
description CD4+ Th cells deliver the cognate and cytokine signals that promote the production of protective virus-neutralizing IgG by specific B cells and are also able to mediate direct antiviral effector functions. To quantitatively and qualitatively analyze the antiviral functions of CD4+ Th cells, we generated transgenic mice (tg7) expressing an MHC class II (I-Ab)-restricted TCR specific for a peptide derived from the glycoprotein (G) of vesicular stomatitis virus (VSV). The elevated precursor frequency of naive VSV-specific Th cells in tg7 mice led to a markedly accelerated and enhanced class switching to virus-neutralizing IgG after immunization with inactivated VSV. Furthermore, in contrast to nontransgenic controls, tg7 mice rapidly cleared a recombinant vaccinia virus expressing the VSV-G (Vacc-IND-G) from peripheral organs. By adoptive transfer of naive tg7 CD4+ T cells into T cell-deficient recipients, we found that 105 transferred CD4+ T cells were sufficient to induce isotype switching after challenge with a suboptimal dose of inactivated VSV. In contrast, naive transgenic CD4+ T cells were unable to adoptively confer protection against peripheral infection with Vacc-IND-G. However, tg7 CD4+ T cells that had been primed in vitro with VSV-G peptide were able to adoptively transfer protection against Vacc-IND-G. These results demonstrate that the antiviral properties of CD4+ T cells are governed by the differentiation status of the CD4+ T cell and by the type of effector response required for virus elimination.
doi_str_mv 10.4049/jimmunol.162.5.2867
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69615294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69615294</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-88f8cbd3c6db3f3ea8cb626115c11354a278e31d693994278efadccaea4b3d9e3</originalsourceid><addsrcrecordid>eNpNkFlLxDAUhYMozrj8AkH6pA_SMUuTto8yrjDiguJjSJNbjXTRJLX4780wM-BTOOE7h8uH0BHBswxn5fmnbduh65sZEXTGZ7QQ-RaaEs5xKgQW22iKMaUpyUU-QXvef2KMBabZLpoQjHPKGZ-it6dBNTaoYH8gUZ1JYu7C5uMZvgfroIUu-KTuXTK_zM6Sl2QOTZPeg7EqgEkuYuHHOtUkj64PoIPtuwO0U6vGw-H63Uev11cv89t08XBzN79YpJoVOKRFURe6MkwLU7GagYpJUEEI14QwnimaF8CIESUry2wZamW0VqCyipkS2D46We1-uf57AB9ka72O56kO-sFLUQrCaZlFkK1A7XrvHdTyy9lWuV9JsFz6lBufMvqUXC59xtbxen6oWjD_OiuBEThdAR_2_WOMrqRvVdNEnMhxHP9N_QFCy4H_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69615294</pqid></control><display><type>article</type><title>Qualitative and Quantitative Requirements for CD4+ T Cell-Mediated Antiviral Protection</title><source>EZB Electronic Journals Library</source><creator>Maloy, Kevin J ; Burkhart, Christoph ; Freer, Giulia ; Rulicke, Thomas ; Pircher, Hanspeter ; Kono, Dwight H ; Theofilopoulos, Argyrios N ; Ludewig, Burkhard ; Hoffmann-Rohrer, Urs ; Zinkernagel, Rolf M ; Hengartner, Hans</creator><creatorcontrib>Maloy, Kevin J ; Burkhart, Christoph ; Freer, Giulia ; Rulicke, Thomas ; Pircher, Hanspeter ; Kono, Dwight H ; Theofilopoulos, Argyrios N ; Ludewig, Burkhard ; Hoffmann-Rohrer, Urs ; Zinkernagel, Rolf M ; Hengartner, Hans</creatorcontrib><description>CD4+ Th cells deliver the cognate and cytokine signals that promote the production of protective virus-neutralizing IgG by specific B cells and are also able to mediate direct antiviral effector functions. To quantitatively and qualitatively analyze the antiviral functions of CD4+ Th cells, we generated transgenic mice (tg7) expressing an MHC class II (I-Ab)-restricted TCR specific for a peptide derived from the glycoprotein (G) of vesicular stomatitis virus (VSV). The elevated precursor frequency of naive VSV-specific Th cells in tg7 mice led to a markedly accelerated and enhanced class switching to virus-neutralizing IgG after immunization with inactivated VSV. Furthermore, in contrast to nontransgenic controls, tg7 mice rapidly cleared a recombinant vaccinia virus expressing the VSV-G (Vacc-IND-G) from peripheral organs. By adoptive transfer of naive tg7 CD4+ T cells into T cell-deficient recipients, we found that 105 transferred CD4+ T cells were sufficient to induce isotype switching after challenge with a suboptimal dose of inactivated VSV. In contrast, naive transgenic CD4+ T cells were unable to adoptively confer protection against peripheral infection with Vacc-IND-G. However, tg7 CD4+ T cells that had been primed in vitro with VSV-G peptide were able to adoptively transfer protection against Vacc-IND-G. These results demonstrate that the antiviral properties of CD4+ T cells are governed by the differentiation status of the CD4+ T cell and by the type of effector response required for virus elimination.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.162.5.2867</identifier><identifier>PMID: 10072535</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject>Adoptive Transfer ; Animals ; Antibodies, Viral - blood ; CD4-Positive T-Lymphocytes - immunology ; Female ; Immunoglobulin Class Switching ; Immunoglobulin G - blood ; Membrane Glycoproteins ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Receptors, Antigen, T-Cell, alpha-beta - physiology ; Vesicular stomatitis Indiana virus - immunology ; Viral Envelope Proteins - immunology ; Virus Diseases - immunology</subject><ispartof>The Journal of immunology (1950), 1999-03, Vol.162 (5), p.2867-2874</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c380t-88f8cbd3c6db3f3ea8cb626115c11354a278e31d693994278efadccaea4b3d9e3</citedby><cites>FETCH-LOGICAL-c380t-88f8cbd3c6db3f3ea8cb626115c11354a278e31d693994278efadccaea4b3d9e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10072535$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maloy, Kevin J</creatorcontrib><creatorcontrib>Burkhart, Christoph</creatorcontrib><creatorcontrib>Freer, Giulia</creatorcontrib><creatorcontrib>Rulicke, Thomas</creatorcontrib><creatorcontrib>Pircher, Hanspeter</creatorcontrib><creatorcontrib>Kono, Dwight H</creatorcontrib><creatorcontrib>Theofilopoulos, Argyrios N</creatorcontrib><creatorcontrib>Ludewig, Burkhard</creatorcontrib><creatorcontrib>Hoffmann-Rohrer, Urs</creatorcontrib><creatorcontrib>Zinkernagel, Rolf M</creatorcontrib><creatorcontrib>Hengartner, Hans</creatorcontrib><title>Qualitative and Quantitative Requirements for CD4+ T Cell-Mediated Antiviral Protection</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>CD4+ Th cells deliver the cognate and cytokine signals that promote the production of protective virus-neutralizing IgG by specific B cells and are also able to mediate direct antiviral effector functions. To quantitatively and qualitatively analyze the antiviral functions of CD4+ Th cells, we generated transgenic mice (tg7) expressing an MHC class II (I-Ab)-restricted TCR specific for a peptide derived from the glycoprotein (G) of vesicular stomatitis virus (VSV). The elevated precursor frequency of naive VSV-specific Th cells in tg7 mice led to a markedly accelerated and enhanced class switching to virus-neutralizing IgG after immunization with inactivated VSV. Furthermore, in contrast to nontransgenic controls, tg7 mice rapidly cleared a recombinant vaccinia virus expressing the VSV-G (Vacc-IND-G) from peripheral organs. By adoptive transfer of naive tg7 CD4+ T cells into T cell-deficient recipients, we found that 105 transferred CD4+ T cells were sufficient to induce isotype switching after challenge with a suboptimal dose of inactivated VSV. In contrast, naive transgenic CD4+ T cells were unable to adoptively confer protection against peripheral infection with Vacc-IND-G. However, tg7 CD4+ T cells that had been primed in vitro with VSV-G peptide were able to adoptively transfer protection against Vacc-IND-G. These results demonstrate that the antiviral properties of CD4+ T cells are governed by the differentiation status of the CD4+ T cell and by the type of effector response required for virus elimination.</description><subject>Adoptive Transfer</subject><subject>Animals</subject><subject>Antibodies, Viral - blood</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>Female</subject><subject>Immunoglobulin Class Switching</subject><subject>Immunoglobulin G - blood</subject><subject>Membrane Glycoproteins</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Transgenic</subject><subject>Receptors, Antigen, T-Cell, alpha-beta - physiology</subject><subject>Vesicular stomatitis Indiana virus - immunology</subject><subject>Viral Envelope Proteins - immunology</subject><subject>Virus Diseases - immunology</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpNkFlLxDAUhYMozrj8AkH6pA_SMUuTto8yrjDiguJjSJNbjXTRJLX4780wM-BTOOE7h8uH0BHBswxn5fmnbduh65sZEXTGZ7QQ-RaaEs5xKgQW22iKMaUpyUU-QXvef2KMBabZLpoQjHPKGZ-it6dBNTaoYH8gUZ1JYu7C5uMZvgfroIUu-KTuXTK_zM6Sl2QOTZPeg7EqgEkuYuHHOtUkj64PoIPtuwO0U6vGw-H63Uev11cv89t08XBzN79YpJoVOKRFURe6MkwLU7GagYpJUEEI14QwnimaF8CIESUry2wZamW0VqCyipkS2D46We1-uf57AB9ka72O56kO-sFLUQrCaZlFkK1A7XrvHdTyy9lWuV9JsFz6lBufMvqUXC59xtbxen6oWjD_OiuBEThdAR_2_WOMrqRvVdNEnMhxHP9N_QFCy4H_</recordid><startdate>19990301</startdate><enddate>19990301</enddate><creator>Maloy, Kevin J</creator><creator>Burkhart, Christoph</creator><creator>Freer, Giulia</creator><creator>Rulicke, Thomas</creator><creator>Pircher, Hanspeter</creator><creator>Kono, Dwight H</creator><creator>Theofilopoulos, Argyrios N</creator><creator>Ludewig, Burkhard</creator><creator>Hoffmann-Rohrer, Urs</creator><creator>Zinkernagel, Rolf M</creator><creator>Hengartner, Hans</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990301</creationdate><title>Qualitative and Quantitative Requirements for CD4+ T Cell-Mediated Antiviral Protection</title><author>Maloy, Kevin J ; Burkhart, Christoph ; Freer, Giulia ; Rulicke, Thomas ; Pircher, Hanspeter ; Kono, Dwight H ; Theofilopoulos, Argyrios N ; Ludewig, Burkhard ; Hoffmann-Rohrer, Urs ; Zinkernagel, Rolf M ; Hengartner, Hans</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-88f8cbd3c6db3f3ea8cb626115c11354a278e31d693994278efadccaea4b3d9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adoptive Transfer</topic><topic>Animals</topic><topic>Antibodies, Viral - blood</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>Female</topic><topic>Immunoglobulin Class Switching</topic><topic>Immunoglobulin G - blood</topic><topic>Membrane Glycoproteins</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Transgenic</topic><topic>Receptors, Antigen, T-Cell, alpha-beta - physiology</topic><topic>Vesicular stomatitis Indiana virus - immunology</topic><topic>Viral Envelope Proteins - immunology</topic><topic>Virus Diseases - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maloy, Kevin J</creatorcontrib><creatorcontrib>Burkhart, Christoph</creatorcontrib><creatorcontrib>Freer, Giulia</creatorcontrib><creatorcontrib>Rulicke, Thomas</creatorcontrib><creatorcontrib>Pircher, Hanspeter</creatorcontrib><creatorcontrib>Kono, Dwight H</creatorcontrib><creatorcontrib>Theofilopoulos, Argyrios N</creatorcontrib><creatorcontrib>Ludewig, Burkhard</creatorcontrib><creatorcontrib>Hoffmann-Rohrer, Urs</creatorcontrib><creatorcontrib>Zinkernagel, Rolf M</creatorcontrib><creatorcontrib>Hengartner, Hans</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maloy, Kevin J</au><au>Burkhart, Christoph</au><au>Freer, Giulia</au><au>Rulicke, Thomas</au><au>Pircher, Hanspeter</au><au>Kono, Dwight H</au><au>Theofilopoulos, Argyrios N</au><au>Ludewig, Burkhard</au><au>Hoffmann-Rohrer, Urs</au><au>Zinkernagel, Rolf M</au><au>Hengartner, Hans</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Qualitative and Quantitative Requirements for CD4+ T Cell-Mediated Antiviral Protection</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>1999-03-01</date><risdate>1999</risdate><volume>162</volume><issue>5</issue><spage>2867</spage><epage>2874</epage><pages>2867-2874</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>CD4+ Th cells deliver the cognate and cytokine signals that promote the production of protective virus-neutralizing IgG by specific B cells and are also able to mediate direct antiviral effector functions. To quantitatively and qualitatively analyze the antiviral functions of CD4+ Th cells, we generated transgenic mice (tg7) expressing an MHC class II (I-Ab)-restricted TCR specific for a peptide derived from the glycoprotein (G) of vesicular stomatitis virus (VSV). The elevated precursor frequency of naive VSV-specific Th cells in tg7 mice led to a markedly accelerated and enhanced class switching to virus-neutralizing IgG after immunization with inactivated VSV. Furthermore, in contrast to nontransgenic controls, tg7 mice rapidly cleared a recombinant vaccinia virus expressing the VSV-G (Vacc-IND-G) from peripheral organs. By adoptive transfer of naive tg7 CD4+ T cells into T cell-deficient recipients, we found that 105 transferred CD4+ T cells were sufficient to induce isotype switching after challenge with a suboptimal dose of inactivated VSV. In contrast, naive transgenic CD4+ T cells were unable to adoptively confer protection against peripheral infection with Vacc-IND-G. However, tg7 CD4+ T cells that had been primed in vitro with VSV-G peptide were able to adoptively transfer protection against Vacc-IND-G. These results demonstrate that the antiviral properties of CD4+ T cells are governed by the differentiation status of the CD4+ T cell and by the type of effector response required for virus elimination.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>10072535</pmid><doi>10.4049/jimmunol.162.5.2867</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof The Journal of immunology (1950), 1999-03, Vol.162 (5), p.2867-2874
issn 0022-1767
1550-6606
language eng
recordid cdi_proquest_miscellaneous_69615294
source EZB Electronic Journals Library
subjects Adoptive Transfer
Animals
Antibodies, Viral - blood
CD4-Positive T-Lymphocytes - immunology
Female
Immunoglobulin Class Switching
Immunoglobulin G - blood
Membrane Glycoproteins
Mice
Mice, Inbred C57BL
Mice, Transgenic
Receptors, Antigen, T-Cell, alpha-beta - physiology
Vesicular stomatitis Indiana virus - immunology
Viral Envelope Proteins - immunology
Virus Diseases - immunology
title Qualitative and Quantitative Requirements for CD4+ T Cell-Mediated Antiviral Protection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T05%3A21%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Qualitative%20and%20Quantitative%20Requirements%20for%20CD4+%20T%20Cell-Mediated%20Antiviral%20Protection&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Maloy,%20Kevin%20J&rft.date=1999-03-01&rft.volume=162&rft.issue=5&rft.spage=2867&rft.epage=2874&rft.pages=2867-2874&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.162.5.2867&rft_dat=%3Cproquest_cross%3E69615294%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c380t-88f8cbd3c6db3f3ea8cb626115c11354a278e31d693994278efadccaea4b3d9e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69615294&rft_id=info:pmid/10072535&rfr_iscdi=true